logo
Workers to bear brunt of health cost increases in 2026

Workers to bear brunt of health cost increases in 2026

Axios14 hours ago
Big employers who've tried to insulate workers from rising health costs are preparing to share the pain next year in the form of higher premiums to reflect year-over-year increases of as much as 10%.
Why it matters: The added costs will hit workers already reeling from inflationary pressures and reflect a change in thinking for corporations that have tried to maintain generous benefits in tight labor markets.
"The story this year is perhaps more daunting and sobering than it ever has been," Ellen Kelsay, CEO of Business Group on Health, said on Tuesday.
By the numbers: A survey the group released of 121 large employers insuring 11.6 million people found companies' medical costs sharply outpaced their expectations over the past two years.
They are now projecting health costs to jump a median of 9% next year absent any cutbacks in benefits to offset the increases.
Employers in Mercer's annual survey forecast a more modest 5.8% increase next year while a separate survey from the International Foundation of Employee Benefit Plans projected a median increase of 10%.
Between the lines: The cost pressures in some ways mirror the experience in Affordable Care Act and other insurance markets that have seen costs surge on higher demand for health procedures and tests and rising drug costs.
Cancer is the top driver of employer health costs for the fourth year in a row, as diagnoses increase and treatment costs grow, according to the Business Group on Health survey.
Employers have also expressed concerns about pricey biologic drugs, anti-inflammatory specialty drugs and the soaring demand for GLP-1s for obesity.
In 2024, pharmacy expenses accounted for nearly a quarter of all employers' health care spending (24%), and the companies project an increase of 11% to 12% next year, per the Business Group on Health.
Employers appear much more reluctant to eat higher benefit costs.
Mercer found 51% said they would be shifting costs to employees this year, up from 44% last year.
"What we had been seeing in the data for quite a few years is employers really not doing a lot of cost-shifting," said Beth Umland, Mercer's director of research for health and benefits.
"As we are entering our third year of elevated cost trend, employers are like, 'All right, we got it. We got to readjust this.'"
They'll also scrutinize other employee health perks.
"Employers are going to do some things much more aggressively ... in terms of holding their vendors accountable and exploring alternatives, because passing cost increases is a Band-Aid approach. It does not fix the long term," Kelsay said.
What to watch: Nearly one-quarter of large employers will have alternative health plan arrangements in place next year, and another 36% are considering them for the future, per the Business Group on Health.
Your employer might even introduce what they call a "high performance network" or "exclusive provider organization" this year.
They sound suspiciously like the HMOs of old as they offer much narrower networks for participants, in exchange for lower rates. But they have key differences. For instance, patients have better tools and data at their disposal via apps on their phone to compare providers' cost and quality.
"They are also, for the most part, avoiding the primary care physician gatekeeper feature. That's the HMO feature that just kind of turned out to be a lightning rod for a lot of people," Umland said.
Zoom out: While the funding cuts and enrollment restrictions on public health insurance programs included in the GOP's tax-and-spending bill don't directly affect employer-sponsored health coverage, they'll likely have ripple effects.
Two-thirds of employers surveyed by Business Group on Health reported being concerned about cuts to Medicaid and Medicare.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Exclusive-CVS holds off adding Gilead's new HIV prevention shot to drug coverage lists
Exclusive-CVS holds off adding Gilead's new HIV prevention shot to drug coverage lists

Yahoo

time2 hours ago

  • Yahoo

Exclusive-CVS holds off adding Gilead's new HIV prevention shot to drug coverage lists

By Deena Beasley (Reuters) -CVS Health, which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told Reuters, despite the medicine's proven effectiveness. CVS based the decision on clinical, financial, and regulatory factors, spokesperson David Whitrap said in an email. It also will not cover Yeztugo under its Affordable Care Act formularies, since its ACA preventive program follows recommendations and mandates from the U.S. Department of Health and Human Services (HHS), Whitrap said. Current HIV prevention recommendations from the U.S. Preventive Services Task Force (USPSTF), which is supported by HHS, include only three older drugs. A source familiar with the situation suggested that Gilead is still negotiating with CVS over Yeztugo, a twice-yearly injection with a U.S. list price of more than $28,000 a year. The decision by CVS is "a grave disappointment and frankly a missed opportunity," said Mitchell Warren, executive director of the AIDS nonprofit AVAC. "It does reflect a price that is too high and a U.S. pharmaceutical pricing structure that is frankly not sustainable." He and other AIDS activists have said Yeztugo could be a transformative tool in ending the 44-year-old epidemic that infects 1.3 million people a year and is estimated by the World Health Organization to have killed more than 42 million. Gilead said it is "extremely pleased" with progress in its conversations with payers, most of whom continue to cover HIV prevention products with no cost sharing or coverage barriers. The company said it is on track to secure 75% U.S. insurer coverage of Yeztugo by year-end and 90% coverage by June 2026. Pharmacy benefit managers, or PBMs, act as middlemen between drug companies and consumers. They negotiate volume discounts with drug manufacturers on behalf of employers and health plans based on coverage terms. The three largest - CVS Caremark, UnitedHealth Group's OptumRX and Cigna's Express Scripts - control about 70% of specialty drug prescriptions in the U.S. Optum said Yeztugo will be reviewed for coverage in the coming weeks, while Express Scripts did not respond to requests for comment. U.S. government healthcare programs, including the Veterans Administration and the Medicare program for people over age 65, have already added Yeztugo to coverage lists. Gilead said earlier this month that several state-run Medicaid plans, including California and New York, were covering the drug. Gilead, its investors, and AIDS activists have high hopes for Yeztugo. Approved in June for people at high risk of HIV, the drug was shown to be nearly 100% effective at preventing infection in large trials, fueling fresh optimism about limiting the spread of the deadly virus. Some analysts have warned that a recent Supreme Court ruling affirming broad HHS authority over the USPSTF could affect coverage prospects while Robert F. Kennedy Jr is in charge of the agency. Medical groups have expressed alarm about reports that Kennedy could replace members of the task force. The 16-member task force reviews evidence and public input, then recommends preventive services that catch disease early or prevent worsening, which insurers must cover without patient cost-sharing. For HIV prevention, it endorses daily PrEP pills Truvada, which is available as a generic, and Gilead's Descovy, as well as ViiV Healthcare's bimonthly shot Apretude. Gilead CEO Daniel O'Day has stressed that the lifetime cost of treating an HIV patient can exceed $1 million, making a preventive treatment cost effective. (Reporting By Deena Beasley; Editing by Patrick Wingrove and Diane Craft)

GLP-1s, cancer care are driving higher employer health care costs in 2026
GLP-1s, cancer care are driving higher employer health care costs in 2026

Boston Globe

time3 hours ago

  • Boston Globe

GLP-1s, cancer care are driving higher employer health care costs in 2026

Advertisement Companies' strategies for managing the ballooning costs, several experts said, will likely skew toward more aggressive scrutiny of their health insurance carriers and other third-party vendors that help them manage costs, and finding alternatives, if necessary. The higher costs raise the prospect of higher insurance premiums and deductibles for workers, though Ellen Kelsay, CEO of the Business Group on Health, said companies will try to shield employees as much as they can. Kelsay called passing costs on to employees 'a Band-Aid approach' that doesn't fix the long-term cost dynamics. 'Employers are still going to be absorbing 90-plus percent of the health care costs,' Kelsay said on a call with reporters. 'They are still going to do their level best to absorb as much of this cost increase as possible.' Advertisement The 9 percent projected median increase is up from an estimated 8 percent this year and reported increases of 7.5 percent in 2024 and 6.8 percent in 2023. Even if workers don't foot the higher costs directly, the climbing costs of health care can limit the growth of their wages over time. The 9 percent increase is on par with other projections. Last week, the The biggest culprit for higher costs in the Business Group on Health survey is increased use of blockbuster GLP-1 drugs for obesity and diabetes, sold under the brand names Wegovy, Ozempic, Zepbound, and Mounjaro. About 80 percent of respondents to the survey said they've seen an uptick in the use of those drugs, and another 15 percent said they anticipate a future increase. To mitigate GLP-1 expenses, the survey found that the number of employers who cover them for conditions other than diabetes will stagnate. Currently, 99 percent of employers surveyed cover them for diabetes and 73 percent cover them for obesity. Only 6 percent of employers said they had dropped coverage for obesity. Employers that cover GLP-1s for obesity said they'll put more hurdles around their use, such as requiring prescriptions from specific providers and requiring users to participate in weight management programs. Such utilization management tactics are already common. The survey found 90 percent of plans require prior authorization and 54 percent require workers to participate in weight management programs. Advertisement Cancer was the top condition driving employers' health care costs for the fourth year in a row, as diagnoses become more prevalent and the cost of treatment rises. Almost 90 percent of employers said cancer was among the top three conditions costing them the most in 2025, up from 80 percent last year. About half of employers plan to steer their workers toward specific cancer centers that offer quality services at lower costs, known as centers of excellence, in 2026, and another 23 percent will consider doing so by 2028. Other conditions were less likely to show up in employers' top three lists for costs. Diabetes dropped from 28 percent in 2024 to 21 percent in 2025. Musculoskeletal conditions dropped from 74 percent to 71 percent and cardiovascular conditions dropped from 40 percent to 35 percent. Almost three-quarters of employers said their workers are seeking out mental health and substance use disorder treatment at higher rates, and another 17 percent anticipate future increases. Another area that's driving higher spending is more coverage for women's health needs. Next year, 58 percent of employers said they plan to expand preventive care for women, an increase of 22 percentage points in two years. Almost 60 percent of employers said they'll provide menopause support services next year, up from 28 percent in 2024. Other services are also on the rise. In 2026, 36 percent of employers will cover doula services, 55 percent will cover services to treat postpartum depression, and 43 percent will cover initiatives to support high-risk pregnancies in under-resourced populations. Robert Andrews, CEO of the Health Transformation Alliance, a coalition of about 80 self-insured employers that cover 5 million people, said that while he hasn't done a formal survey, he's hearing that costs are rising 7 percent to 9 percent at the median. That said, some of his group's members have kept costs flat. The latter are companies that are aggressive about auditing claims and not paying erroneous, fraudulent, or otherwise inflated claims. Advertisement Another piece of advice Andrews gives members is to carefully review their agreements with carriers. 'Watch your carrier very closely, audit the carrier, make sure you're getting the deal that you bargained for,' he said. Andrews also recommends companies put a cap on out-of-network charges for employees who have to get care at out-of-network hospitals. Not only that, make sure the insurer is actually enforcing the cap, because often it's not, he said. One of the Business Group on Health's members is Delta Airlines, where the cost increases are consistently in the low single digits, said Henry Ting, the company's chief health and wellness officer. 'That's not just an accident or by chance,' said Ting, a cardiologist who worked at Mayo Clinic for over two decades. 'We do take a lot of actions to make sure we're delivering the best value.' Delta's approach to keeping health insurance costs down Delta has collected over 10 billion de-identified records from its 100,000 employees and their dependents and used it to see where the high costs are. One revelation was that a significant percentage of cancers among employees were diagnosed because of symptoms and not through screening tests. Those people also tended to have more advanced disease. Delta now has a 'Living Well with Dr. Henry' series for employees in which Ting educates people on screenings. Advertisement 'Then we make it easy for them to schedule those appointments without a lot of friction,' Ting said. 'I'd like to have 99 percent of our cancers diagnosed on a routine screening test rather than feeling a lump or pain or bleeding.' The Commonwealth Fund last year convened a One of the task force members is Paul Fronstin, who serves as director of health benefits research at the Employee Benefit Research Institute. When it comes to strategies for cutting down on costs, Fronstin said he thinks employers will scrutinize vendors, make changes to plan designs and networks, and use so-called point solutions, which are vendors that help patients manage specific conditions, like type 2 diabetes or mental health conditions. But with unemployment still at record lows, Fronstin thinks retention will be front of mind for employers, making them hesitant to shift costs onto employees. 'We've seen in the past that employers haven't increased premiums,' he said, 'or to the degree premiums have gone up for employees, they've gone up in proportion to what the employer pays.'

Mark Cuban Wants You To Stop Saving Money (And Do This Instead)
Mark Cuban Wants You To Stop Saving Money (And Do This Instead)

Yahoo

time4 hours ago

  • Yahoo

Mark Cuban Wants You To Stop Saving Money (And Do This Instead)

A little over half of Americans (56%) have less than $2,000 in savings, according to a 2024 Forbes survey. One in five Americans (20%) doesn't have savings at all. Read Next: Learn More: While saving is important, it's not the only way to build wealth. In fact, billionaire Mark Cuban argues that you shouldn't just save — you should invest instead. GOBankingRates broke down Cuban's advice on prioritizing investing your money over saving it. Aggressively Invest Instead According to Mark Cuban, saving isn't the best way to make your money work for you. The top 1% doesn't just save. They aggressively invest in things like real estate and alternative assets (like gold IRAs). A 2025 CAIS-Mercer study supports this idea. Of the financial advisors surveyed, 92% said they allocate their funds to alternative investments. Nearly all of them (91%) said they intend to increase allocations in the future. Take Mark Cuban's Advice With a Grain of Salt Leaving your money in a savings account, even one with higher-than-normal yields, might not be the best idea. After all, those yields may not even keep up with inflation. This means the value of your savings might fall rather than rise (depending on the account and how much you're contributing). But you might still want to have a little saved for emergencies. 'Every individual should have [three to six] months of lifestyle expenses in savings — a checking account and a high-yield money market account. Once they have this money in savings, they should start investing,' said Richard Craft, CEO of Wealth Advisory Group. You can save money for short-term goals — anything that takes under a year. But if you have long-term goals — anything over a year — investing is generally smarter. For You: Saving Could Cost You Millions Say you have a savings account with 4.00% APY and a $50,000 balance. After one year, you'd have roughly $52,000. In 10 years, you'd have around $74,000. This assumes nothing changes in that account — no withdrawals, deposits or changes in yield. Now, say you invest $50,000 in the stock market instead. According to the stock market has seen an average annual return of 10.8% over the past decade. Assuming average returns and no additional contributions, you'd have nearly $140,000 after 10 years. That's nearly double — all because you invested. When you think even longer term, you could potentially be losing out on a lot more than that. 'I think of investing and saving as one in the same,' said Paul Gabrail, founder and host at Everything Money. 'Saving for a 'rainy day' or for an emergency fund is not a wise financial move in my opinion. This could cost you millions in retirement.' He continued, 'Instead, all savings should go into investing. Essentially you are still saving; you're saving for retirement.' Consider Opportunity Cost While many experts suggest having an emergency fund, some take a different approach — one that may more closely align with Mark Cuban's. Saving comes with an opportunity cost, meaning the loss of a potential gain. 'If we're talking about saving for something like an emergency fund, then I think they should stop immediately and consider the opportunity cost,' said Gabrail. 'You can always use a credit card for a true emergency. Put that money towards investing in your retirement instead.' Take Your Risk Tolerance Into Account Not everyone has the same risk tolerance. And not everyone is in the same place in life financially. While going straight to investing might work for some, it's not the best move for everyone. Consider your goals and needs when choosing what to do with your money. When in doubt, speak with a professional for advice. More From GOBankingRates 3 Luxury SUVs That Will Have Massive Price Drops in Summer 2025 9 Downsizing Tips for the Middle Class To Save on Monthly Expenses How Much Money Is Needed To Be Considered Middle Class in Your State? This article originally appeared on Mark Cuban Wants You To Stop Saving Money (And Do This Instead) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store